How has Corvus Pharmaceuticals's rental income nonoperating changed year-over-year?

Corvus Pharmaceuticals's rental income nonoperating decreased by 86.7% year-over-year, from $146.75K to $19.5K.

Corvus Pharmaceuticals CRVS Rental Income Nonoperating

Rental Income Nonoperating at other companies

KRT

Karat PackagingKRT

$698K-10.1%

PopularBPOP

$3.48M+20.9%

Bar Harbor BanksharesBHB

$682K+49.6%

BankUnitedBKU

$3.35M-22.4%

BancFirst CorporationBANF

-$3.61M-35.6%

Pathward Financial, Inc.CASH

$10.95M-17.1%

Other financials

Income statement

See full

Operating income-$14.9M-49.9%

Net income-$13.7M-190%

EPS (diluted)-$0.15-15.4%

Balance sheet

See full

Cash & equivalents$40.1M+702%

Total debt$834.0K-27.7%

Total equity$240.7M+388%

Total assets$253.2M+326%

Cash flow

See full

Operating cash flow-$10.4M-25.5%

CapEx$91.0K+153%

Free cash flow-$10.5M-26.1%

Valuation

See full

Market cap$1.1B+259%

Enterprise value$1.06B+251%

Returns & leverage

See full

Return on equity-30.5%-12.5pp

Debt / equity0×0.0×

Current ratio19.8×+14.9×

Where this comes from

Reported directly by Corvus Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RentalIncomeNonoperating.

The official record: Corvus Pharmaceuticals’s 10-K, filed March 25, 2025, on SEC EDGAR. View the filing →

Ask your AI about Corvus Pharmaceuticals's rental income nonoperating.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Corvus Pharmaceuticals's rental income nonoperating?: Corvus Pharmaceuticals (CRVS) reported rental income nonoperating of $19.5K in Q4 2023.
How has Corvus Pharmaceuticals's rental income nonoperating changed year-over-year?: Corvus Pharmaceuticals's rental income nonoperating decreased by 86.7% year-over-year, from $146.75K to $19.5K.